Methylparaben Confirmed as Endocrine Disruptor: What Formulators Need to Know

Methylparaben — the most widely used preservative in cosmetics and personal care products — has been formally confirmed as an endocrine disruptor under European chemicals law. A Substance Evaluation Conclusion published on 7 April 2026 by the French Agency for Food, Environmental and Occupational Health Safety (ANSES), acting on behalf of the French Ministry of Ecological Transition, marks a significant regulatory milestone. For formulators, brands, and ingredient suppliers, the findings demand attention.

What Is a Substance Evaluation Conclusion Under REACH?

Before unpacking the science, it helps to understand the regulatory context. Under the REACH Regulation (EC) No 1907/2006, substances can be placed on the Community Rolling Action Plan (CoRAP) when concerns are identified about their potential hazard to human health or the environment. Methylparaben (EC 202-785-7; CAS 99-76-3) was first added to CoRAP back in 2014 — its evaluation has therefore been underway for over a decade.

The Substance Evaluation Conclusion document, required under Article 48 of REACH, sets out what the evaluating Member State Competent Authority (in this case France/ANSES) has concluded from all available evidence. It is not itself a binding regulatory restriction — but it is an important precursor to harmonised classification, labelling, and potentially restriction measures.

The Key Finding: Endocrine Disruption Confirmed

The central conclusion of the April 2026 document is unambiguous. Three hazard concerns were confirmed following the full evaluation:

• Reproductive toxicity
• Endocrine disruption — human health
• Endocrine disruption — environment

ANSES concludes that methylparaben fulfils the criteria for endocrine disruption (ED) for both human health and the environment under the new CLP hazard categories introduced by Commission Delegated Regulation (EU) 2023/707. Additionally, concern for male fertility was identified as potentially warranting a reprotoxic classification under CLP.

By contrast, two initial concerns — skin sensitisation and skin irritation — were removed following evaluation, meaning no EU-level follow-up is needed for those endpoints.

What Regulatory Actions Are Proposed?

The April 2026 conclusion document proposes the following regulatory pathway:

Harmonised Classification and Labelling (CLH)

France/ANSES intends to submit a CLH proposal for methylparaben in 2027. This would formally classify methylparaben under the CLP Regulation as:

• Reprotoxic (effects on male fertility, and potentially fertility more broadly — details to be determined in the CLH dossier)
• Endocrine disruptor for both human health and environment, using the new CLP ED hazard categories introduced by EU 2023/707

Restriction Under REACH (Potential Future Action)

A restriction proposal is being considered after the CLH process. ANSES notes that if restriction is deemed necessary, it should cover the broader paraben family — including ethyl-, propyl-, and butylparaben as a minimum — to prevent regrettable substitution. The restriction should also address paraben esters currently listed in Annex V, Entry 12 of the Cosmetics Regulation.

SVHC Identification

Formal identification as a Substance of Very High Concern (SVHC) under Article 57f is not considered at this stage, but would depend on the outcome of the CLH process.

The Paraben Family in Broader Context

Methylparaben is not alone in facing regulatory scrutiny. The evaluation document provides useful context across the paraben family:

• Butylparaben has already been identified as SVHC based on endocrine disrupting properties for human health
• Isobutylparaben has also been identified as SVHC (largely based on butylparaben data)
• Propylparaben was similarly evaluated by Belgian authorities, who concluded endocrine disruption for the environment
• Benzylparaben and isobutylparaben are banned in cosmetics (Annex II of Regulation 358/2014)

Current cosmetic use limits under Annex V of Regulation (EC) No 1223/2009 allow methylparaben at up to 0.4% as a single ester and 0.8% for paraben mixtures. Butyl- and propylparaben were separately restricted to 0.14% combined since 2015, with additional restrictions for use in nappy-area products for under-threes. Future restriction moves are likely to draw on a whole-family approach.

What This Means for Green Cosmetic Formulators

The formal confirmation of methylparaben as an endocrine disruptor is a significant signal — even before any binding restriction is in force. Here is what formulators and brands working in sustainable beauty should take from this update:

1. The regulatory direction is clear. Harmonised ED classification under CLP (expected 2027 CLH submission, with classification likely to follow in subsequent years) will have downstream effects across the supply chain, including on SDS requirements, risk assessments, and potentially labelling.

2. Consumer pressure will intensify. Even without a current ban, classification as an endocrine disruptor will increase pressure from retailers, certification bodies, and consumers for paraben-free formulations — particularly in products targeting sensitive populations (pregnant women, infants, and children).

3. The ‘methylparaben is safe because it’s the mildest paraben’ argument is weakening. While methylparaben does have lower estrogenic potency than longer-chain relatives, this evaluation confirms it shares the same mechanism of action and the same adverse endpoint profile. Its potentially higher anti-androgenic activity relative to longer-chain parabens is a nuance that will feature in future classification discussions.

4. Formulation without parabens is achievable. Green preservation science has matured considerably. Multi-hurdle approaches, bioferment-based preservation, optimised pH and water activity management, and approved natural antimicrobials provide robust alternatives. Formulators should document preservation efficacy thoroughly as they transition away from paraben-containing systems.

5. Watch for the CLH dossier in 2027. When France submits the harmonised classification proposal, there will be a public consultation period. This is an opportunity for industry — including ingredient suppliers — to provide relevant data.

Mutagenicity and Carcinogenicity: Not Yet Resolved

Two initial concerns — mutagenicity and carcinogenicity — were assessed as inconclusive in this document, meaning no regulatory action is proposed yet but the issues remain open. The mutagenicity picture is complex: bacterial mutation assays are negative, but chromosome aberration data with metabolic activation, and epidemiological data linking methylparaben to sperm DNA damage, leave uncertainty. ANSES notes that an in vivo comet assay in liver would have been needed for a definitive conclusion, but this was not requested as part of the evaluation. These remain areas to monitor.

A Note on Environmental Ubiquity

Perhaps the most striking finding in the environmental sections of this document is not the toxicology, but the monitoring data. Methylparaben has been found in Antarctic waters, in polar bear livers, and in all samples from the Norman database monitoring of French surface waters (near 100% detection frequency). It has been detected in human placenta, breast milk, cord blood, and amniotic fluid. The conclusion that releases from widespread consumer use “cannot be avoided” underpins the anticipated direction of travel toward restriction.

Summary

Restriction: Under consideration, to follow CLH outcome — expected to cover broader paraben family if pursued.

Further Reading

• ECHA Substance Evaluation Conclusion: Methyl 4-hydroxybenzoate (EC 202-785-7), ANSES, 7 April 2026
• ECHA Assessment of Regulatory Needs for Parabens (2022)
• SCCS Final Opinion on Methylparaben (SCCS/1652/23)
• Commission Delegated Regulation (EU) 2023/707 — new CLP hazard classes for endocrine disruptors

To know more about the history of this assessment read our article about France proposal regarding Methylaparaben or if you wish to explore Methylparaben alternatives please visit the GreenChemFidner compendium